Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelinesMichael Hallek, Thomas J. Kipps, Bruce D. Cheson et al.|Blood|2008Cited by 3.2k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLLMichael Hallek, Thomas J. Kipps, Bruce D. Cheson et al.|Blood|2018Cited by 1.7k
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative TherapySergio Giralt, Richard E. Champlin, Elihu H. Estey et al.|Blood|1997Cited by 1.2k
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic LeukemiaMichael J. Keating, Hagop M. Kantarjian, Susan O’Brien et al.|Journal of Clinical Oncology|2005Cited by 951
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international studyMichael J. Keating, Ian W. Flinn, Vinay Jain et al.|Blood|2002Cited by 946